Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.4607
-0.0315 (-6.40%)
At close: Oct 27, 2026, 4:00 PM EDT
0.4550
-0.0057 (-1.24%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $49.39 million as of October 27, 2026. It is the 30,199th most valuable company in the world and the 4,617th biggest in the United States. Its market cap has decreased by 78.70% in one year.
Market Cap
49.39M
Enterprise Value
-37.77M
1-Year Change
-78.70%
Global Rank
Country Rank
#4,617 United States
Category
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $49.39M, a decrease of -94.44%. That is a compound annual growth rate of -42.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 49.39M | -66.77% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 60.64M |
| XBiotech | 58.84M |
| Gossamer Bio | 58.75M |
| RenovoRx | 58.22M |
| OS Therapies | 57.76M |
| Heron Therapeutics | 57.49M |
| Clene | 55.15M |
| Gain Therapeutics | 54.99M |